Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the efficacy and safety of adipose-derived mesenchymal stromal cells (AD-MSCs) plus calipcitriol ointmen…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis [Phase 1]
Phase 1 trial of a single dose of spesolimab in generalized pustular psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating the safe and effective use of the prefilled syringe or auto-injector for subcutaneous self-injection of bimekizumab…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Chinese Medicine for Patients With Psoriasis [Phase 2]
A Phase 2 clinical trial update investigating Chinese Medicine for patients with psoriasis is listed, with the sponsor as The Chinese Univer…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Efficacy of Roflumilast in the Treatment of Psoriasis [Phase 2]
Phase 2 clinical trial update on roflumilast for psoriasis has completed evaluating efficacy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Roflumilast Versus Methotrexate in Psoriasis [Phase 2, Phase 3]
Clinical trial comparing roflumilast to methotrexate in psoriasis has completed Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis [Phase 4]
Phase 4 clinical trial examining the effects of biological agents on vascular and cardiac function in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 study evaluating guselkumab in adults with moderate-to-severe plaque psoriasis has completed and posted results (May 10, 2023).
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis [Phase 2]
Phase 2 trial of once-weekly oral aminopterin for moderate-to-severe psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis [Phase 3]
Phase 3 randomized placebo-controlled study of ISA247 in plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]
Phase 2 clinical trial completed evaluating maximal usage pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis [Phase 4]
Phase 4 real-world study assessing long-term quality of life in adults with psoriasis treated with tildrakizumab.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial update on AVT04 evaluating efficacy, safety, and immunogenicity in moderate-to-severe chronic plaque psoriasis; study complete…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis [Phase 3]
A Phase 3 trial evaluating BMS-986165 (deucravacitinib) versus placebo and active comparator in psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated [Phase 4]
Phase 4 non-inferiority trial assessing dose reduction of adalimumab in psoriasis patients who are overtreated has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis [Phase 2]
Phase 2 trial of EDP1815 for mild to moderate plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of apremilast in adults with moderate to severe genital psoriasis has completed and posted …
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is [Phase 2]
Phase 2 trial assessing longer-term tolerability and efficacy of BI 730357 in plaque psoriasis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Vascular Inflammation in Psoriasis - Apremilast [Phase 4]
Phase 4 clinical trial update on apremilast for vascular inflammation in psoriasis has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 study update of a recombinant anti-IL-17A monoclonal antibody in Chinese patients with moderate-to-severe psoriasis.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis [Phase 3]
Phase 3 trial updates for BMS-986165 in Japanese participants with moderate-to-severe psoriasis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea [Phase 3]
Phase 3 trial POETYK-PSO-3 evaluating BMS-986165 vs placebo in plaque psoriasis across several Asian regions has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Excimer Laser With Topical Agents in Psoriasis Vulgaris [Phase 4]
Phase 4 clinical trial evaluating excimer laser with topical agents for psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating Metaderm product for psoriasis, with completed status and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis [Phase 2]
Phase 2 trial update of CD 2027 spray evaluated for efficacy and safety in plaque-type psoriasis; results posted after completion.